DDIS-05. IDENTIFICATION OF 2-FLUORO PALMITIC ACID AS A POTENTIAL THERAPEUTIC AGENT AGAINST GLIOBLASTOMA

BACKGROUND: Glioblastoma (GBM) represents the most aggressive and frequent type of primary malignant brain tumors with a dismal clinical outcome. Though adjuvant temozolomide (TMZ) chemotherapy followed by surgical resection can extend patient`s post-operative survival, a considerable number of GBM...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Jiapaer, Shabierjiang, Dong, Yu, Kitabayashi, Tomohiro, Furuta, Taskuya, Sabit, Hemragul, Zhang, Jiakang, Zhang, guangtao, Tanaka, Shingo, Nakada, Mitsutoshi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2019
Aiheet:
Drug Discovery
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847336/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.265
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia